RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-κB signaling pathways

J Zhu, Y Zhang, L Shi, Y Xia, H Zha, H Li… - International …, 2022 - Elsevier
J Zhu, Y Zhang, L Shi, Y Xia, H Zha, H Li, Z Song
International Immunopharmacology, 2022Elsevier
Acute kidney injury (AKI) is a critical and severe clinical disease caused by a variety of
factors. Toll-like receptors (TLRs) play a crucial role in pathogenesis of AKI. Radioprotective
105 kDa protein (RP105) is a member of the TLR family, but the role of RP105 in AKI is
unknown. In this study, we overexpressed RP105 in renal tissue and cultured proximal
tubular cells in which we then induced ischemic and septic AKI. Renal structure injuries
were examined by hematoxylin eosin staining, while renal function was assessed by …
Abstract
Acute kidney injury (AKI) is a critical and severe clinical disease caused by a variety of factors. Toll-like receptors (TLRs) play a crucial role in pathogenesis of AKI. Radioprotective 105 kDa protein (RP105) is a member of the TLR family, but the role of RP105 in AKI is unknown. In this study, we overexpressed RP105 in renal tissue and cultured proximal tubular cells in which we then induced ischemic and septic AKI. Renal structure injuries were examined by hematoxylin eosin staining, while renal function was assessed by measuring serum blood urea nitrogen (BUN) and creatinine (SCr) levels. The TUNEL assay was used to detect apoptosis induced changes in the expression of RP105, and nuclear factor κB (NF-κB) in renal tissue detected by Western blot. Inflammatory cytokines including iNOS, IL-1β, IL-6, and TNF-α were detected by quantitative real-time PCR. The inflammatory indicators, F4/80 and MPO, were identified by IHC staining. The results showed that expression of the TLR4/NF-kB signaling pathway was enhanced in renal ischemia–reperfusion injury and septic renal injury, and that overexpression of RP105 in renal tissue alleviated ischemic and septic AKI. Moreover, RP105 gene delivery was associated with reduced renal inflammatory cells infiltration and inflammatory cytokines after AKI. RP105 overexpression also inhibited nuclear translocation of NF-κB after AKI in both in vitro and in vivo, and blunted the interaction between Myeloid Differentiation factor 2 (MD2) and TLR4. These results indicated that RP105 protected against renal ischemic and septic AKI injury by suppressing inflammatory responses mediated by TLR4 signaling pathways. This study suggests that the anti-inflammatory roles of RP105 have potential for preventing and treating renal ischemic and septic AKI.
Elsevier